Ambu A/S (OTCMKTS:AMBBY) Sets New 52-Week Low – What’s Next?

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) hit a new 52-week low during trading on Tuesday . The stock traded as low as $9.51 and last traded at $9.51, with a volume of 415 shares. The stock had previously closed at $9.70.

Ambu A/S Price Performance

The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.73 and a current ratio of 2.92. The firm has a market capitalization of $2.23 billion, a price-to-earnings ratio of 33.96 and a beta of 0.99. The business has a fifty day moving average of $10.13 and a two-hundred day moving average of $11.76.

Ambu A/S (OTCMKTS:AMBBY) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.07 earnings per share (EPS) for the quarter. Ambu A/S had a return on equity of 8.03% and a net margin of 7.81%.The business had revenue of $246.39 million during the quarter.

About Ambu A/S

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.